UK markets closed

Akoya Biosciences, Inc. (AKYA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.5600+0.2300 (+9.87%)
As of 03:22PM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
93,573
96,633
74,859
54,917
42,443
-
Cost of revenue
41,182
40,328
31,469
20,699
16,535
-
Gross profit
52,391
56,305
43,390
34,218
25,908
-
Operating expenses
Research development
21,065
21,889
23,211
15,701
9,603
-
Selling general and administrative
79,120
82,381
79,653
51,016
23,982
-
Total operating expenses
108,252
112,337
109,598
71,443
37,400
-
Operating income or loss
-55,861
-56,032
-66,208
-37,225
-11,492
-
Interest expense
9,319
8,761
4,554
3,115
2,723
-
Total other income/expenses net
-6,412
-1,979
-533
-2,826
-2,449
-
Income before tax
-67,931
-63,283
-70,518
-43,075
-16,664
-
Income tax expense
74
40
123
-140
42
-
Income from continuing operations
-68,005
-63,323
-70,641
-42,935
-16,706
-
Net income
-68,005
-63,323
-70,641
-42,935
-16,706
-
Net income available to common shareholders
-68,005
-63,323
-70,641
-44,370
-21,762
-
Basic EPS
-1.73
-
-1.87
-1.65
-0.75
-0.63
Diluted EPS
-1.73
-
-1.87
-1.65
-0.75
-0.63
Basic average shares
41,516
-
37,747
26,897
28,916
28,916
Diluted average shares
41,516
-
37,747
26,897
28,916
28,916